Risk factors analysis of complications after cerebrovascular bypass in patients with moyamoya disease

doi:10.3969/j.issn.1672-6731.2022.05.009

Abstract

Abstract: Objective To analyze the relationship between the preoperative relative blood glucose ratio and the safety of cerebrovascular bypass of ischemic moyamoya disease (MMD) patients. Methods A total of 178 patients with ischemic MMD who were hospitalized in Department of Neurosurgery of Qilu Hospital of Shandong University from December 2016 to December 2019. A total of 186 cases underwent superficial temporal artery-middle cerebral artery (STA-MCA) bypass. The fasting blood glucose and glycated albumin of all patients at admission were recorded to calculate the relative blood glucose ratio. After STA-MCA bypass, the incidence of postoperative complications was counted. Univariate and multivariate Logistic regression were used to analyze the risk factors of postoperative complications of ischemic MMD. Results 186 cases were divided into 4 groups based on relative blood glucose ratio, Q1 < 0.404, Q2 0.404-, Q3 0.456-, Q4 ≥ 0.534. The proportion of right surgery side in Q1 group was higher than that in Q3 group (χ²=4.762, P=0.029) and Q4 group (χ²=22.087, P=0.000), while the proportion of right surgery side in Q2 group (χ²=16.331, P=0.000) and Q3 group (χ²=7.355, P=0.007) was higher than that in Q4 group. The incidence of mild complications in Q1 group (χ²=6.389, P=0.011) and Q2 group (χ²=4.040, P=0.044) was higher than that in Q4 group. The incidence of postoperative complications was 28.49% (53/186), of which 8.60% (16/186) were severe type and 19.89% (37/186) were mild type, including transient neurological dysfunction 97.30% (36/37), subdural hemorrhage 2.70% (1/37). Logistic regression analysis showed that the relative blood glucose ratio increased (OR=1.484, 95%CI:1.071-2.058; P=0.018), hypertension (OR=3.696, 95%CI:1.805-7.569; P=0.000), operative interval < 2 months (OR=2.186, 95%CI:1.041-4.590; P=0.039) was risk factors for postoperative complications. Conclusions In order to reduce the incidence of postoperative complications in patients with ischemic MMD, the operation interval after infarction can be extended to 2 months, and the preoperative relative blood glucose ratio should be closely monitored and the perioperative blood pressure should be controlled.

Key words: Moyamoya disease, Stroke, Brain ischemia, Blood glucose, Cerebral revascularization, Postoperative complications, Logistic models

摘要： 目的分析缺血型烟雾病患者术前相对血糖比值与脑血管搭桥术安全性之间的关系。方法以2016年12月至2019年12月在山东大学齐鲁医院神经外科住院治疗的178例缺血型烟雾病患者为观察对象，共行186例次颞浅动脉-大脑中动脉搭桥术。收集患者入院时空腹血糖和糖化血清白蛋白数据、计算相对血糖比值，记录术后并发症发生率；单因素与多因素Logistic回归分析筛查术后并发症危险因素。结果术后并发症发生率为28.49%（53/186），其中，重型占8.60%（16/186），均为症状性脑梗死；轻型占19.89%（37/186），其中短暂性神经功能障碍97.30%（36/37）、硬膜下出血2.70%（1/37）。Logistic回归分析显示，高血压（OR=3.696，95% CI：1.805~7.569；P=0.000）、手术间隔< 2个月（OR=2.186，95% CI：1.041~4.590；P=0.039）、相对血糖比值升高（OR=1.484，95% CI：1.071~2.058；P=0.018）是术后并发症的危险因素。结论烟雾病患者急性缺血性发作后脑血管搭桥术时间可延长至2个月后，同时关注术前相对血糖比值、严格控制围手术期血压，以降低术后并发症发生风险。

关键词: 脑底异常血管网病, 卒中, 脑缺血, 血糖, 脑血管重建术, 手术后并发症, Logistic模型

LIU Kai-ning, SUN Tao, HAN Meng-tao, ZHANG Ping, ZHAO Peng, WANG Dong-hai, LI Gang. Risk factors analysis of complications after cerebrovascular bypass in patients with moyamoya disease[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2022, 22(5): 380-385.

刘恺宁, 孙涛, 韩孟桃, 张平, 赵鹏, 王东海, 李刚. 缺血型烟雾病脑血管搭桥术后并发症危险因素分析[J]. 中国现代神经疾病杂志, 2022, 22(5): 380-385.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2022.05.009

https://journal11.magtechjournal.com/cjcnn/EN/Y2022/V22/I5/380

References

[1] Shang S, Zhou D, Ya J, Li S, Yang Q, Ding Y, Ji X, Meng R. Progress in moyamoya disease[J]. Neurosurg Rev, 2020, 43:371-382.
[2] Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease[J]. Exp Ther Med, 2019, 17:1977-1984.
[3] Sun Y, Wang BL, Li Q, Tong XG. Clinical analysis of low flow bypass in the treatment of chronic symptomatic middle cerebral artery occlusion[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2021, 21:547-552.[孙杨, 王本琳, 李琪, 佟小光. 低流量血管搭桥术治疗慢性症状性大脑中动脉闭塞疗效分析[J]. 中国现代神经疾病杂志, 2021, 21:547-552.]
[4] Yu GD, Tong ZY, Liu Y, Wang G, Zhang JS, Chu JG. The controlled trial of superficial temporal artery-anterior cerebral artery and superficial temporal artery-middle cerebral artery double barrel bypass in patients with moyamoya disease[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2021, 21:537-546.[余冠东, 佟志勇, 刘源, 王刚, 张劲松, 初金刚. 颞浅动脉-大脑前动脉和颞浅动脉-大脑中动脉双搭桥术治疗烟雾病的对照研究[J]. 中国现代神经疾病杂志, 2021, 21:537-546.]
[5] Hayashi K, Horie N, Suyama K, Nagata I. Incidence and clinical features of symptomatic cerebral hyperperfusion syndrome after vascular reconstruction[J]. World Neurosurg, 2012, 78:447-454.
[6] Li X, Qing ZZ, Niu JX, He X, Wang ZZ. The analysis of postoperative complications and the influencing factors during the treatment of revascularization of moyamoya disease[J]. Yi Xue Yu Zhe Xue, 2016, 37:53-57.[李鑫, 秦至臻, 牛建星, 何心, 王建祯. 血管重建术治疗烟雾病术后并发症发生及其影响因素分析[J]. 医学与哲学, 2016, 37:53-57.]
[7] Fujimura M, Niizuma K, Endo H, Sato K, Inoue T, Shimizu H, Tominaga T. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease[J]. Neurol Res, 2015, 37:131-138.
[8] Li F, Li C, Sun Y, Bao Y, Jiang W, Song Z, Wang Y, Liu M, Wang W, Li T, Li L. Cerebral ischemic complications after surgical revascularization for moyamoya disease:risk factors and development of a predictive model based on preoperative nutritional blood parameters[J]. Front Nutr, 2022, 9:842838.
[9] Ngiam JN, Cheong CWS, Leow AST, Wei YT, Thet JKX, Lee IYS, Sia CH, Tan BYQ, Khoo CM, Sharma VK, Yeo LLL. Stress hyperglycaemia is associated with poor functional outcomes in patients with acute ischaemic stroke after intravenous thrombolysis[J]. QJM, 2022, 115:7-11.
[10] Pan Y, Cai X, Jing J, Meng X, Li H, Wang Y, Zhao X, Liu L, Wang D, Johnston SC, Wei T, Wang Y; CHANCE Investigators. Stress hyperglycemia and prognosis of minor ischemic stroke and transient ischemic attack:the CHANCE study (Clopidogrel in high-risk patients with acute nondisabling cerebrovascular events)[J]. Stroke, 2017, 48:3006-3011.
[11] Shimoyama T, Kimura K, Uemura J, Saji N, Shibazaki K. Elevated glucose level adversely affects infarct volume growth and neurological deterioration in non-diabetic stroke patients, but not diabetic stroke patients[J]. Eur J Neurol, 2014, 21:402-410.
[12] Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O'Dea H, Stranks SN, Burt MG, Doogue MP. Relative hyperglycemia, a marker of critical illness:introducing the stress hyperglycemia ratio[J]. J Clin Endocrinol Metab, 2015, 100:4490-4497.
[13] Lee TF, Drake SM, Roberts GW, Bersten A, Stranks SN, Heilbronn LK, Mangoni AA, Burt MG. Relative hyperglycemia is an independent determinant of in-hospital mortality in patients with critical illness[J]. Crit Care Med, 2020, 48:e115-122.
[14] Xu S, Zhang J, Wang S, Li Z, Xiong Z, Wu X, Xin C, Wang H, Wang Y, Chen J. The optimum operative time of revascularization for patients with moyamoya disease following acute onset[J]. World Neurosurg, 2018, 114:e412-416.
[15] Ma Y, Zhao M, Deng X, Zhang D, Wang S, Zeng Z, Zhang Q, Zhao J. Comparison of clinical outcomes and characteristics between patients with and without hypertension in moyamoya disease[J]. J Clin Neurosci, 2020, 75:163-167.
[16] Chen Y, Ma L, Lu J, Chen X, Ye X, Zhang D, Zhang Y, Wang R, Zhao Y. Postoperative hemorrhage during the acute phase after direct or combined revascularization for moyamoya disease:risk factors, prognosis, and literature review[J]. J Neurosurg, 2019, 18:1-10.
[17] Liming Z, Weiliang S, Jia J, Hao L, Yang L, Ludtka C, Jahromi BR, Goehre F, Zemmar A, Tianxiao L, Hernesniemi J, Andrade-Barazarte H, Chaoyue L. Impact of blood pressure changes in cerebral blood perfusion of patients with ischemic moyamoya disease evaluated by SPECT[J]. J Cereb Blood Flow Metab, 2021, 41:1472-1480.
[18] Uchino H, Kazumata K, Ito M, Nakayama N, Kuroda S, Houkin K. Crossed cerebellar diaschisis as an indicator of severe cerebral hyperperfusion after direct bypass for moyamoya disease[J]. Neurosurg Rev, 2021, 44:599-605.
[19] Nielsen TH, Abhinav K, Sussman ES, Han SS, Weng Y, Bell-Stephens T, Heit JJ, Steinberg GK; CNRN. Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease:results of an individualized selection strategy[J]. J Neurosurg, 2020, 134:1578-1589.
[20] Lu J, Li Z, Zhao Y, Chen X, Shi G, Zhao J. Hemorrhagic transformation in ischemic moyamoya disease:clinical characteristics, radiological features, and outcomes[J]. Front Neurol, 2020, 11:517.
[21] Gupta SK, Narayanan R, Aggarwal A, Mohanty M, Ahuja C, Verma N, Praneeth K, Agarwal V. Outcome following surgical revascularization in patients of moyamoya disease with focus on graft patency and angiographic changes[J]. Neurol India, 2021, 69:620-627.

Please choose a citation manager

Content to export